Insight

Andres Ricaurte Fajardo: How dural-based metastases can be distinguished from meningioma

Photo taken from Andres Ricaurte Fajardo/X

Sep 9, 2024, 13:38

Andres Ricaurte Fajardo: How dural-based metastases can be distinguished from meningioma

Andres Ricaurte Fajardo, Molecular Imaging and Theranostics Researcher at Weil Cornell Medicine, shared a post on X:

“Thrilled to be part of this study highlighting how dural-based metastases rare yet significant in prostate cancer can be distinguished from meningioma, using Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA PET). This underscores the value of targeted PET in Prostate Cancer.
Congratulations Divya Yadav, Jana Ivanidze.”

PSMA PET improves characterization of dural-based intracranial lesions in patients with metastatic prostate cancer published in ScienceDirect.

Additional information
Source: Andres Ricaurte Fajardo/X

Andres Ricaurte Fajardo Andrew Brandmaier cancer Divya Yadav Jana Ivanidze Joseph R. Osborne meningioma OncoDaily Oncology prostate cancer PSMA PET Silvina P. Dutruel Weil Cornell Medicine

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage